Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches.

Selection of CMV antiviral treatment should be determined by patient-specific factors, including severity of illness, resistant or refractory disease, dose-limiting adverse effects, and the preferred route of administration.